Use of Bromine-76 and Iodine-123 Radiohalogenated Tracers in the Drug Development Process

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|18|1931-1943

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.18, 2001-12, pp. : 1931-1943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positron Emitting Tracers in Pre-Clinical Drug Development

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 2, 2012-04 ,pp. : 90-98

Bentham Science Publishers

Access to resources Recommend Favorite

Iodine-123/iodine-131: Iododerma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

The drug development process: from target discovery to the clinic

By Newell David R  

Clinical Medicine, Vol. 3, Iss. 4, 2003-07 ,pp. : 323-326

Royal College Of Physicians

Access to resources Recommend Favorite

Applications of Molecular Imaging in Drug Discovery and Development Process

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 459-468

Bentham Science Publishers

Access to resources Recommend Favorite

The Power of Enzyme Kinetics in the Drug Development Process

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 5, 2013-06 ,pp. : 551-560

Bentham Science Publishers

Access to resources Recommend Favorite